Skip to content

Clinical trials

Phase 3 Tuberculosis, Multidrug-Resistant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberculosis, Multidrug-Resistant Phase: Phase 3 Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20111
20131
20143
20152
20162
20171
20192
20201
20211
20222
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting4
Not yet recruiting2
Active, not recruiting2
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Global Alliance for TB Drug Development3
Huashan Hospital3
Médecins Sans Frontières, France2
Seoul National University Hospital2
Assistance Publique - Hôpitaux de Paris1
Beijing Chest Hospital1
IUATLD, Inc1
Immunitor LLC1
Institute of Tropical Medicine, Belgium1
Janssen Infectious Diseases BVBA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberculosis, Multidrug-Resistant22
Tuberculosis13
Tuberculosis, Pulmonary8
Extensively Drug-Resistant Tuberculosis5
Bacterial Infections2
Gram-Positive Bacterial Infections1
Mycobacterium Infections1

Trials

Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.